STAGE IIIB BREAST CANCER
Clinical trials for STAGE IIIB BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new STAGE IIIB BREAST CANCER trials appear
Sign up with your email to follow new studies for STAGE IIIB BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New vaccine aims to train immune system against breast cancer stem cells
⭐️ VACCINE ⭐️ OngoingThis early-phase trial tests a DNA vaccine called STEMVAC in 42 people with advanced HER2-negative breast cancer that is stable or gone after standard treatment. The vaccine is designed to help the immune system recognize and attack cancer stem cells, which are often resistant to…
Matched conditions: STAGE IIIB BREAST CANCER
Phase: PHASE1 • Sponsor: University of Washington • Aim: ⭐️ VACCINE ⭐️
Last updated May 06, 2026 16:14 UTC
-
New hope for hard-to-treat breast cancer: immune-boosting combos tested
Disease control OngoingThis study tests whether combining an immunotherapy drug (avelumab) with other targeted drugs can shrink or control advanced triple-negative breast cancer that has spread or come back. About 145 adults with stage IV or inoperable breast cancer are taking part. The goal is to see …
Matched conditions: STAGE IIIB BREAST CANCER
Phase: PHASE2 • Sponsor: Laura Huppert, MD, BA • Aim: Disease control
Last updated May 09, 2026 05:36 UTC
-
Immune booster before chemo shows promise for tough breast cancers
Disease control OngoingThis study tests whether giving two immunotherapy drugs (decitabine and pembrolizumab) before standard chemotherapy can increase immune cell activity in breast tumors. It involves 46 people with locally advanced HER2-negative breast cancer, divided by hormone receptor status. The…
Matched conditions: STAGE IIIB BREAST CANCER
Phase: PHASE2 • Sponsor: Virginia Commonwealth University • Aim: Disease control
Last updated May 09, 2026 05:34 UTC
-
New hope for breast cancer: Pre-Surgery combo may shrink tumors
Disease control OngoingThis study tests whether giving chemotherapy (paclitaxel and cyclophosphamide) with or without the targeted drug trastuzumab before surgery can shrink breast tumors and reduce the amount of breast tissue that needs to be removed. It includes 92 women with early-stage or locally a…
Matched conditions: STAGE IIIB BREAST CANCER
Phase: PHASE2 • Sponsor: University of Nebraska • Aim: Disease control
Last updated May 09, 2026 05:33 UTC
-
New hope: hormone combo may shrink breast tumors better before surgery
Disease control OngoingThis phase 3 study tests whether giving a combination of two hormone-blocking drugs (fulvestrant and anastrozole) before surgery works better than anastrozole alone for shrinking estrogen receptor-positive breast cancer in postmenopausal women. About 1,473 women with stage II or …
Matched conditions: STAGE IIIB BREAST CANCER
Phase: PHASE3 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated May 07, 2026 18:38 UTC
-
New chemo combo shows promise against tough breast cancer
Disease control OngoingThis study tested giving two chemotherapy drugs (carboplatin and nab-paclitaxel) before surgery to people with a fast-growing type of breast cancer called triple negative. The goal was to shrink tumors enough so that no cancer remains at the time of surgery. 67 patients with adva…
Matched conditions: STAGE IIIB BREAST CANCER
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 04, 2026 16:22 UTC